Related Experiment Videos
Adherence to guidelines to prevent cardiovascular diseases: The LifeLines cohort study
J W Balder1, S Scholtens, J K de Vries
1Department of Pediatrics, Section Molecular Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
The Netherlands Journal of Medicine
|August 29, 2015
Summary
Undertreatment of lipid-lowering drugs (LLD) for cardiovascular disease (CVD) prevention is high in the Netherlands. Many eligible patients, especially for primary prevention and stroke, do not use LLDs, indicating a gap in CVD risk management.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Statin therapy is proven to reduce CVD burden, yet undertreatment persists.
- National guidelines exist for CVD prevention and treatment.
Purpose of the Study:
- To assess lipid-lowering drug (LLD) use in the Netherlands.
- To evaluate adherence to national CVD prevention guidelines.
- To identify gaps in primary and secondary CVD prevention.
Main Methods:
- Analysis of 70,292 participants from the population-based LifeLines cohort study.
- Assessment of eligibility for LLD prescription based on national guidelines.
- Comparison of eligible individuals with reported LLD use.
Main Results:
- 77% of individuals eligible for primary CVD prevention and 31% for secondary prevention were not using LLDs.
- Patients with diabetes mellitus showed higher LLD use (67%) for primary prevention.
- Only 47% of stroke patients reported LLD treatment for secondary prevention.
Conclusions:
- Adherence to CVD treatment guidelines in the Netherlands is a significant challenge.
- Improved public awareness and enhanced primary/secondary prevention strategies are crucial.
- Addressing undertreatment of LLDs can reduce CVD-related morbidity and mortality.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
858
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
858
01:26Atherosclerosis III: Management
589
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
01:27Coronary Artery Disease V: Interprofessional Care
418
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
01:27Peripheral Artery Disease III: Interprofessional Care
583
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583
01:23Assessment of the Cardiovascular System I: Subjective Data
1.1K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
845
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
845